Skip Nav Destination
1-8 of 8
Keywords: Telogen effluviumClose
Alfredo Rossi, Francesca Magri, Alvise Sernicola, Simone Michelini, Gemma Caro, Marta Muscianese, Marco Di Fraia, Camilla Chello, Maria Caterina Fortuna, Teresa Grieco
Skin Appendage Disord (2021) 7 (5): 377–381.
Published Online: 08 July 2021
... reports have focused on telogen effluvium (TE) as a possible sequela of COVID-19. We assessed 14 cases of hair loss occurring after SARS-CoV-2 infection using trichoscopy and trichogram to investigate patterns related to COVID-19. Furthermore, we discussed possible mechanisms involved in COVID-19 TE. Case...
Skin Appendage Disord (2020) 6 (6): 329–337.
Published Online: 23 August 2020
... clinical trials (RCTs) and 2 prospective cohort studies demonstrated positive effects of topical and oral supplements containing SP (100–320 mg) among patients with androgenetic alopecia (AGA) and telogen effluvium. Sixty percent improvement in overall hair quality, 27% improvement in total haircount...
Sergio Vañó-Galván, David Saceda-Corralo, Ulrike Blume-Peytavi, Jose Cucchía, Ncoza C. Dlova, Maria Fernanda Reis Gavazzoni Dias, Ramon Grimalt, Daniela Guzmán-Sánchez, Matthew Harries, Anthony Ho, Susan Holmes, Jorge Larrondo, Anisa Mosam, Rui Oliveira-Soares, Giselle M. Pinto, Bianca M. Piraccini, Rodrigo Pirmez, Daniel De la Rosa Carrillo, Lidia Rudnicka, Jerry Shapiro, Rodney Sinclair, Antonella Tosti, Ralph M. Trüeb, Annika Vogt, Mariya Miteva
Skin Appendage Disord (2019) 5 (5): 309–315.
Published Online: 02 April 2019
...) with 3,133 diagnoses of alopecia were included (73% were non-cicatricial and 27% were cicatricial alopecias). In all, 57 different types of alopecia were characterized. The most frequent type was androgenetic alopecia (AGA) (37.7%), followed by alopecia areata (AA) (18.2%), telogen effluvium (TE) (11.3...
Skin Appendage Disord (2018) 4 (1): 29–30.
Published Online: 06 July 2017
...Alfredo Rebora References 1. Trüeb RM: Telogen effluvium: is there a need for a new classification? Skin Appendage Disord 2016;2:39-44. 2. Rebora A: Alopecia areata incognita. J Am Acad Dermatol 2011;65:1228. 3. Rebora A: Alopecia areata incognita: a comment. Clinics (Sao Paulo...
Skin Appendage Disord (2017) 3 (4): 193–196.
Published Online: 12 May 2017
... and successfully executed. Exogen ends when the shaft is liberated. Accordingly, human hairs would be preferably released not with telogen but with exogen roots. To better understand this somehow revolutionary point and what occurs in telogen effluvium (TE) and in androgenetic alopecia (AGA), we undertook...
Skin Appendage Disord (2017) 3 (1): 7–14.
Published Online: 17 December 2016
... no primary disease of the scalp (Table 4 ). The most common preexisting scalp dermatoses were androgenetic alopecia (34.5%), acute telogen effluvium (9.7%), chronic telogen effluvium (8.4%), seborrheic dermatitis (6.2%), and alopecia areata (4.9%). Associated scalp disorders included psoriasis, psoriasiform...
Skin Appendage Disord (2016) 2 (1-2): 35–38.
Published Online: 18 May 2016
...Alfredo Rebora Telogen effluvium (TE) is a pathogenically heterogeneous condition which so far has been classified into acute and chronic forms - or, according to Headington, into 5 different pathogenetic forms. Regrettably, Headington's classification is difficult to apply in the office, and most...
Skin Appendage Disord (2016) 1 (3): 141–143.
Published Online: 19 November 2015
... minoxidil solution with severe telogen effluvium and psoriasiform scalp dermatitis. Scalp dermoscopy was useful to identify the psoriasiform vascular pattern, whereas patch testing made it possible to differentiate the cause of sensitization. In one case, minoxidil was the sole cause of scalp dermatitis...